Last 45 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.00 | 32.14 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 123.81 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.00 | 0.20 | 3.33 | 3.12 | 4.04 | 2.89 | 3.16 | 3.19 | 4.91 | 5.54 | 5.87 | 10.04 | 12.20 | 6.47 | 8.03 | 9.16 | 18.10 | 13.90 | 20.37 | 18.13 | 24.22 |
| — | -93.1% | +5.5% | -2.3% | -17.6% | -47.8% | -46.2% | -68.2% | -59.8% | -14.3% | -27.0% | +9.6% | -32.6% | -53.5% | -60.6% | -49.5% | -25.3% | -26.3% | +0.4% | -24.7% | +106.9% | |
| P/B Ratio | 0.00 | 2.55 | 70.25 | 310.13 | 41.26 | 22.28 | 11.89 | 11.33 | 14.05 | 15.18 | 12.83 | 19.60 | 19.11 | 12.57 | 13.87 | 14.94 | 21.44 | 19.81 | 24.00 | 20.75 | 23.39 |
| — | -88.6% | +491.0% | +2636.1% | +193.6% | +46.8% | -7.3% | -42.2% | -26.5% | +20.8% | -7.5% | +31.2% | -10.9% | -36.6% | -42.2% | -28.0% | -8.3% | +1.2% | +36.5% | +43.2% | +108.2% | |
| P/FCF | — | — | — | — | — | 139.18 | — | 109.39 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | 4.18 | — | — | — | — | — | 35.19 | — | — | 58.59 | — | — | 43.25 | 128.10 | — | — | 242.67 | 257.61 | 3516.21 | — |
| — | — | — | — | — | — | — | — | — | — | -54.3% | — | — | -82.2% | -50.3% | — | — | +0.3% | — | — | — | |
| EV / EBIT | — | 106.59 | — | — | — | — | — | 68.67 | — | — | — | — | — | 517.39 | — | — | — | 87.72 | — | 120.16 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | +489.8% | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 58.3% | 60.4% | 60.4% | 56.2% | 53.5% | 60.1% | 60.3% | 58.5% | 45.6% | 55.3% | 56.0% | 52.3% | 58.0% | 64.6% | 61.6% | 54.8% | 58.6% | 66.2% | 69.7% | 64.5% | 63.7% |
| — | +0.5% | +0.1% | -4.0% | +17.4% | +8.8% | +7.8% | +11.8% | -21.4% | -14.5% | -9.2% | -4.6% | -1.1% | -2.5% | -11.6% | -15.0% | -8.0% | -2.0% | +21.2% | +32.3% | -2.5% | |
| Operating Margin | -19.0% | 0.4% | -26.8% | -29.0% | -29.6% | -44.1% | -18.8% | -5.8% | -42.8% | -39.6% | -6.9% | -23.8% | -34.2% | 1.3% | -8.4% | -18.6% | -32.7% | -6.9% | -6.0% | -12.5% | -41.1% |
| — | +100.9% | -42.6% | -403.7% | +30.8% | -11.5% | -170.5% | +75.8% | -25.2% | -3233.3% | +16.8% | -27.8% | -4.5% | +118.4% | -38.5% | -48.8% | +20.3% | -31.1% | +70.8% | +68.8% | -191.4% | |
| Net Margin | -20.4% | 0.6% | -23.4% | -32.5% | -35.7% | -47.0% | -24.1% | -1.2% | -49.9% | -43.7% | -11.9% | -38.2% | -37.5% | -1.5% | -10.6% | -20.8% | -35.5% | -9.4% | -6.8% | 14.7% | -41.5% |
| — | +101.3% | +3.0% | -2667.4% | +28.4% | -7.6% | -102.8% | +96.9% | -33.1% | -2793.4% | -12.5% | -83.6% | -5.4% | +83.9% | -56.4% | -241.8% | +14.4% | -42.1% | +69.8% | +135.2% | -169.8% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -158.9% | 2.7% | -200.0% | -167.2% | -63.7% | -62.8% | -22.5% | -1.0% | -30.5% | -26.3% | -6.4% | -17.4% | -13.8% | -0.7% | -4.5% | -8.2% | -10.2% | -3.3% | -2.0% | 4.3% | -9.7% |
| — | +104.4% | -787.8% | -15884.6% | -109.0% | -139.1% | -254.1% | +94.0% | -121.0% | -3482.4% | -41.1% | -111.8% | -35.5% | +77.7% | -124.9% | -289.3% | -5.2% | -92.5% | +57.9% | +170.7% | -164.8% | |
| ROA | -18.8% | 0.2% | -5.3% | -7.7% | -6.9% | -11.8% | -5.3% | -0.2% | -8.2% | -8.5% | -2.1% | -6.0% | -5.6% | -0.3% | -1.9% | -3.5% | -4.9% | -1.8% | -1.1% | 2.4% | -5.2% |
| — | +101.6% | +0.7% | -2980.1% | +15.9% | -38.5% | -158.6% | +95.9% | -46.8% | -2704.5% | -10.4% | -73.3% | -13.6% | +83.3% | -63.9% | -246.0% | +5.7% | -92.7% | +57.7% | +165.5% | -135.5% | |
| ROIC | -34.4% | 0.3% | -13.1% | -14.3% | -11.3% | -19.3% | -6.3% | -1.8% | -10.3% | -11.1% | -1.9% | -6.1% | -7.8% | 0.4% | -2.7% | -6.2% | -8.3% | -2.2% | -1.5% | -2.8% | -7.0% |
| — | +101.3% | -107.7% | -712.1% | -10.4% | -72.8% | -231.2% | +70.9% | -31.4% | -2736.6% | +30.6% | +2.0% | +5.9% | +119.1% | -81.6% | -122.6% | -17.9% | -118.4% | +54.5% | +36.7% | -185.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 5.59 | 5.59 | 12.41 | 53.09 | 6.14 | 3.31 | 1.76 | 1.74 | 1.75 | 1.23 | 0.97 | 0.93 | 0.43 | 0.39 | 0.38 | 0.35 | 0.34 | 0.32 | 0.31 | 0.34 | 0.45 |
| — | +69.2% | +603.9% | +2953.8% | +250.3% | +168.3% | +81.9% | +86.5% | +304.0% | +218.7% | +153.0% | +163.4% | +29.5% | +22.4% | +24.1% | +5.3% | -25.0% | -24.8% | -27.0% | -18.6% | +45.7% | |
| Debt / EBITDA | — | 17.25 | — | — | — | — | — | 19.58 | — | — | 17.01 | — | — | 5.27 | 14.11 | — | — | 15.62 | 13.37 | 228.18 | — |
| — | — | — | — | — | — | — | — | — | — | +20.5% | — | — | -66.3% | +5.6% | — | — | -24.8% | — | — | — | |
| Current Ratio | 0.58 | 0.58 | 0.95 | 0.98 | 1.05 | 1.13 | 1.13 | 1.14 | 1.05 | 1.28 | 1.64 | 1.50 | 1.11 | 1.30 | 1.32 | 1.30 | 1.32 | 1.56 | 1.65 | 1.32 | 1.20 |
| — | -48.6% | -16.0% | -13.7% | -0.3% | -11.1% | -31.1% | -24.3% | -5.4% | -2.1% | +23.8% | +16.0% | -15.9% | -16.4% | -19.7% | -1.7% | +10.2% | +18.3% | +23.6% | -8.3% | -11.6% | |
| Quick Ratio | 0.48 | 0.48 | 0.75 | 0.75 | 0.87 | 0.98 | 0.94 | 0.92 | 0.84 | 1.06 | 1.13 | 1.09 | 0.68 | 0.89 | 0.92 | 0.96 | 0.99 | 1.29 | 1.38 | 1.15 | 1.03 |
| — | -51.3% | -20.2% | -18.0% | +4.2% | -7.2% | -17.3% | -15.5% | +24.1% | +18.7% | +22.3% | +13.6% | -31.9% | -30.8% | -33.2% | -16.8% | -4.2% | +13.4% | +20.6% | -6.7% | -10.1% | |
| Interest Coverage | -2.19 | 0.08 | -2.26 | -4.07 | -4.00 | -8.06 | -2.95 | 0.81 | -5.43 | -2.19 | -0.99 | -9.56 | -8.91 | 0.49 | -3.08 | -8.10 | -11.57 | 6.90 | -8.92 | 58.53 | -108.36 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 45 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SSKN stock.
STRATA Skin Sciences, Inc.'s current P/E is -0.0x. The average P/E over the last 1 quarters is 32.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
STRATA Skin Sciences, Inc.'s current operating margin is -19.0%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking STRATA Skin Sciences, Inc.'s business trajectory between earnings reports.